Lite Strategy (LITS) Return on Capital Employed Growth (1y) (2012 - 2026)
Lite Strategy (LITS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | 7,352.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,352.00 |
| Dec 31, 2025 | 13,033.00 |
| Sep 30, 2025 | 13,507.00 |
| Jun 30, 2025 | -12,634.00 |
| Mar 31, 2025 | -19,160.00 |
| Dec 31, 2024 | -19,018.00 |
| Sep 30, 2024 | -19,076.00 |
| Jun 30, 2024 | 6,463.00 |
| Mar 31, 2024 | 7,009.00 |
| Dec 31, 2023 | 5,479.00 |
| Sep 30, 2023 | 8,582.00 |
| Jun 30, 2023 | 1,238.00 |
| Mar 31, 2023 | 629.00 |
| Dec 31, 2022 | 549.00 |
| Sep 30, 2022 | -609.00 |
| Jun 30, 2022 | -890.00 |
| Mar 31, 2022 | -2,129.00 |
| Dec 31, 2021 | -2,511.00 |
| Sep 30, 2021 | -3,056.00 |
| Jun 30, 2021 | -1,936.00 |